<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04323722</url>
  </required_header>
  <id_info>
    <org_study_id>ICO-2019-15</org_study_id>
    <nct_id>NCT04323722</nct_id>
  </id_info>
  <brief_title>Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer</brief_title>
  <acronym>MESORECT-VV</acronym>
  <official_title>Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Cancerologie de l'Ouest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Cancerologie de l'Ouest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is assessing how Bladder filling variations and thus mesorectal movements are less&#xD;
      when radiotherapy treatment is received with an empty bladder in rectal cancer&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to show that the variations of bladder volume and mesorectal&#xD;
      movements are less with empty versus filled bladder in rectal cancer.&#xD;
&#xD;
      In this study, patient will be treated with 3D conformal radiotherapy (3D-CRT) radiotherapy&#xD;
      with a filled bladder condition, as per standard care, in supine position. A total dose of 45&#xD;
      or 50 Gy in 25 fractions, 5 fractions per week is received.&#xD;
&#xD;
      A Chest, abdomen and pelvis imaging will be performed before treatment start. Patients&#xD;
      receive planning CT scan with filled bladder and then with empty bladder on the same day.&#xD;
      Only planning CT scan with filled bladder will be used patient treatment.&#xD;
&#xD;
      During radiotherapy treatment, patient will receive CBCTs with filled ans empty bladder on&#xD;
      Day 1 ; 2 and 3 on the first week and once a week after.&#xD;
&#xD;
      Multiple parameters will be assessed before treatment (using planning CT scan) and during&#xD;
      radiotherapy treatment (CBCTs) in empty ans filled bladder conditions : Bladder volume,&#xD;
      mesorectal movements.&#xD;
&#xD;
      A dosimetric study will be performed in Intensity-modulated radiotherapy (IMRT) in empty and&#xD;
      filled bladder conditions&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2020</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Monocentric, open prospective study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate using imaging techniques and dosimetric analysis the performance of empty versus filled bladder radiotherapy treatment</measure>
    <time_frame>3.5 years</time_frame>
    <description>Throughout the radiotherapy treatment, the reproducibility of positioning of the anterior surface of mesorectum will be assessed with empty and filled bladder</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate using imaging techniques and dosimetric analysis the performance of empty versus filled bladder radiotherapy treatment</measure>
    <time_frame>3.5 years</time_frame>
    <description>Throughout the radiotherapy treatment, the reliability of positioning of the anterior surface of mesorectum will be assessed with empty and filled bladder</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate mesorectal movements during radiotherapy in empty versus filled bladder</measure>
    <time_frame>3.5 years</time_frame>
    <description>Compare mesorectal movements during radiotherapy treatment compared to the planning CT scan in the case of a filled versus an empty bladder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate changes in bladder volume during radiotherapy in empty versus filled bladder</measure>
    <time_frame>3.5 years</time_frame>
    <description>Compare changes in bladder volume during treatment versus planning CT scan for filled bladder versus empty bladder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IMRT (Intensity-Modulated Radiotherapy) dosimetric study in patients with filled or empty bladder</measure>
    <time_frame>3.5 years</time_frame>
    <description>Compare and validate (in silico on planning CT scan) the compliance with dose constraints to organs-at-risk in patients with filled or empty bladder in IMRT</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Empty bladder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Planning CT scan and CBCTs with empty bladder after standard Planning CT scan and CBCTs with filling bladder</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Empty Bladder planning CT scan and CBCTs</intervention_name>
    <description>Patient will receive a Planning CT scan, 3 CBCTs on the first week and once a week during radiotherapy treatment with an Empty Bladder</description>
    <arm_group_label>Empty bladder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Histologically confirmed rectal adenocarcinoma&#xD;
&#xD;
          -  T2 N+ or T3 any N, eligible for radiotherapy or neo-adjuvant radio-chemotherapy&#xD;
             treatment in a long course of 25 fractions&#xD;
&#xD;
          -  Performance Status less or equal to 2&#xD;
&#xD;
          -  Male or female 18 Years and older&#xD;
&#xD;
          -  Creatinine clearance greater than or equal to 50ml/min&#xD;
&#xD;
          -  Fertile patients must use effective contraception&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Patient must be affiliated to a Social Health Insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous treatment with pelvic radiotherapy&#xD;
&#xD;
          -  Chronic inflammatory bowel disease in flare-up.&#xD;
&#xD;
          -  Urinary catheterization, urinary diversion or cystectomy&#xD;
&#xD;
          -  Hip prosthesis&#xD;
&#xD;
          -  History of prostatectomy, or hysterectomy&#xD;
&#xD;
          -  Urinary incontinence &gt; 2&#xD;
&#xD;
          -  Pregnant or nursing patient&#xD;
&#xD;
          -  Persons deprived of their liberty, as well as adults subject to a legal protection&#xD;
             measure&#xD;
&#xD;
          -  Impossibility to submit to the medical follow-up of this clinical trial for&#xD;
             geographical, social or psychological reasons&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Emmanuel RIO, MD</last_name>
    <phone>+33240679900</phone>
    <email>emmanuel.rio@ico.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nadia ALLAM, PhD</last_name>
    <phone>+33240679826</phone>
    <email>nadia.allam@ico.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut de Cacerologie de l'ouest - site Paul Papin</name>
      <address>
        <city>Angers</city>
        <zip>49055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amaury Paumier, MD</last_name>
      <phone>+33241352700</phone>
      <email>Amaury.Paumier@ico.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICO Ren√© Gauducheau</name>
      <address>
        <city>Saint-Herblain</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel RIO, MD</last_name>
      <phone>+33240679900</phone>
      <email>emmanuel.rio@ico.unicancer.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2020</study_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>3D conformal radiotherapy (3DCRT)</keyword>
  <keyword>Intensity-modulated radiotherapy (IMRT)</keyword>
  <keyword>bladder filling</keyword>
  <keyword>mesorectal movements</keyword>
  <keyword>filled bladder</keyword>
  <keyword>empty bladder</keyword>
  <keyword>cone-beam computerized tomography (CBCT)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

